| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | APPLIED GENETIC TECHNOL CORP | 100,000 | 1,398,000 | 0.51% | ||
| 52 | INTRA-CELLULAR THERAPIES INC | 50,000 | 1,390,000 | 0.51% | ||
| 53 | TANDEM DIABETES CARE INC COM | 150,000 | 1,307,000 | 0.48% | ||
| 54 | CYTOKINETICS INC | 175,000 | 1,234,000 | 0.45% | ||
| 55 | ARATANA THERAPEUTICS INC | 200,000 | 1,104,000 | 0.40% | ||
| 56 | TRINET GROUP INC COM | 75,000 | 1,076,000 | 0.39% | ||
| 57 | BLUEBIRD BIO INC COM | 25,000 | 1,063,000 | 0.39% | ||
| 58 | ONCOMED PHARMACEUTICALS INC | 100,000 | 1,011,000 | 0.37% | Call | |
| 59 | SAREPTA THERAPEUTICS INC | 50,000 | 976,000 | 0.36% | Call | |
| 60 | Heartware International, Inc. | 30,000 | 943,000 | 0.35% | ||
| 61 | AERIE PHARMACEUTICALS INC COM | 75,000 | 912,000 | 0.33% | ||
| 62 | PUMA BIOTECHNOLOGY | 30,000 | 881,000 | 0.32% | ||
| 63 | IGNYTA INC COM | 125,000 | 846,000 | 0.31% | ||
| 64 | FLUIDIGM CORP DEL COM | 100,000 | 807,000 | 0.30% | ||
| 65 | CARDIOVASCULAR SYS INC DEL COM | 75,000 | 778,000 | 0.29% | ||
| 66 | ARIAD PHARMACEUTICALS ORD (NMS) | 100,000 | 639,000 | 0.23% | ||
| 67 | PACIFIC BIOSCIENCES CALIF IN | 75,000 | 638,000 | 0.23% | ||
| 68 | EXELIXIS INC | 150,000 | 600,000 | 0.22% | ||
| 69 | ENDOCHOICE HLDGS INC | 115,000 | 599,000 | 0.22% | ||
| 70 | FORWARD PHARMA A/S | 30,000 | 510,000 | 0.19% | ||
| 71 | SCYNEXIS INC | 125,000 | 504,000 | 0.18% | ||
| 72 | SANGAMO THERAPEUTICS INCORPORATED | 75,000 | 454,000 | 0.17% | ||
| 73 | DERMIRA INC | 20,000 | 414,000 | 0.15% | Put | |
| 74 | ACCELERATE DIAGNOSTICS INC | 25,000 | 359,000 | 0.13% | Call | |
| 75 | ARIAD PHARMACEUTICALS INC | 50,000 | 320,000 | 0.12% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001597549-16-000018, filed 2016.05.24).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
